Development and Validation of the Body Concealment Scale for Scleroderma

Lisa R Jewett1, Vanessa L Malcarne2, Linda Kwakkenbos1

  • 1McGill University and the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Arthritis Care & Research
|December 15, 2015
PubMed
Summary

The Body Concealment Scale for Scleroderma (BCSS) effectively measures how systemic sclerosis patients hide their appearance, aiding in understanding social avoidance and improving quality of life.